Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
120,192,308
-
Total 13F shares
-
16,085,109
-
Share change
-
+16,085,109
-
Total reported value
-
$281,644,000
-
Price per share
-
$17.51
-
Number of holders
-
43
-
Value change
-
+$281,643,584
-
Number of buys
-
43
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q3 2018
As of 30 Sep 2018,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,085,109 shares.
The largest 10 holders included
Crestline Management, LP, PERCEPTIVE ADVISORS LLC, ALLIANCEBERNSTEIN L.P., BlackRock Inc., Vanguard Group Inc, Park West Asset Management LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, ASCEND CAPITAL, LLC, WASATCH ADVISORS INC, and BAKER BROS. ADVISORS LP.
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.